TFX insider trading
NYSE HealthcareTELEFLEX INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About TELEFLEX INC
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Company website: www.teleflex.com
TFX insider activity at a glance
FilingIQ has scored 857 insider transactions for TFX since Feb 20, 2015. The most recent filing in our index is dated May 9, 2026.
Across the full history, 13 open-market purchases
and 274 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TFX insider trades is 60.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
13F funds holding TFX
Frequently asked
- How many insider trades does FilingIQ track for TFX?
- FilingIQ tracks 857 Form 4 insider transactions for TFX (TELEFLEX INC), covering filings from Feb 20, 2015 onwards. 25 of those were filed in the last 90 days.
- Are TFX insiders net buyers or net sellers?
- Across the full Form 4 history for TFX, 13 transactions (2%) were open-market purchases and 274 (32%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TFX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TFX in?
- TELEFLEX INC (TFX) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $5.00B.
Methodology & sources
Every TFX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.